First Horizon Advisors’s Prometheus Biosciences, Inc. Common Stock RXDX Stock Holding History

First Horizon Advisors’s Portfolio RXDX Stock Details RXDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-165	Closed	-$17.7K	–	2555
2023 Q1	$17.7K	Sell	165 -9	-5%	-$1.04K	﹤0.01%	1304
2022 Q4	$19.1K	Buy	+174	New	+$11.3K	﹤0.01%	1269

Other funds holding RXDX

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

FCA

FinTrust Capital Advisors Greenville, South Carolina $591M AUM 26.89% 1-Year Est. Return

First Horizon Advisors's RXDX Position: Q2 2023 in Review

First Horizon Advisors sold out of Prometheus Biosciences, Inc. Common Stock (RXDX) in Q2 2023, closing a stake of 165 shares — an estimated $17.7K sold.

First Horizon Advisors first reported a position in RXDX in Q4 2022 and held it in 2 quarters. The position peaked at $19.1K in Q4 2022. 2 funds tracked by Wall St. Rank hold RXDX as of Q2 2023.

First Horizon Advisors reported no remaining Prometheus Biosciences, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
First Horizon Advisors sold 165 Prometheus Biosciences, Inc. Common Stock shares in Q2 2023, an estimated $17.7K.
First Horizon Advisors first reported a position in Prometheus Biosciences, Inc. Common Stock in Q4 2022 and held it in 2 quarters.
First Horizon Advisors's Prometheus Biosciences, Inc. Common Stock position peaked at $19.1K in Q4 2022.
2 funds tracked by Wall St. Rank held Prometheus Biosciences, Inc. Common Stock as of Q2 2023.

Based on First Horizon Advisors's 13F filing for Q2 2023, filed 3 Aug 2023.